-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Names & News
-
In Brief for Feb. 8, 2023
Dr. Carolyn Dresler Joins Action on Smoking and Health (ASH) Board of Trustees; Novel Liquid Biopsy Assay for Lung Carcinoma Detection Receives FDA Breakthrough Device Designation.
-
IASLC Announces New JTO CRR Editor-in-Chief
Dr. Emily Stone will succeed JTO Clinical and Research Reports founding editor Dr. Alex A. Adjei, who will remain editor-in-chief of the Journal of Thoracic Oncology.
-
ILCN Names New Associate Editors
Long-time editorial group members, Drs. Mary Jo Fidler, Witold Rzyman, and Suresh Senan bring disciplinary diversity to ILCN’s leadership.
-
In Brief for October 12, 2022
Former IASLC board member Dr. Carolyn Dresler recently honored for her lifetime of tobacco control advocacy. Penn Medicine chosen as site for US National Cancer Institute Telehealth Research Center of Excellence.
-
Beloved Oncologist Dr. Philip D. Bonomi to Retire June 30, 2022
After nearly 50 years of patient care at Rush University Medical Center, Dr. Bonomi will retire from his clinical service.
-
Reflections on Nearly 50 Years in Oncology
Philip D. Bonomi, MD, who specializes in caring for those with lung cancer, has made many contributions to the field during his 47 years of service.
-
Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture
The honor of giving the opening keynote address during ELCC recognizes Dr. Hirsch’s significant contributions to international research and education.
-
In Brief for May 25, 2022
5th edition of patient education book released; US FDA moves to prohibit tobacco flavoring.
-
In Brief for May 11, 2022
Winship Cancer Institute announces preceptor opportunity. NICE recommends tepotinib for select patients.
-
Valuable Intersections: Maximizing Career Opportunities Arising From The Relationship Between Academia and Industry
For Dr. Jean-Charles Soria, the opportunity to make science actionable and increase its impact drove his decision to work in industry.